Arthrosi Therapeutics

Arthrosi Therapeutics develops pharmaceutical treatments through clinical research and drug development programs.

Latest funding

$153M Series B+ · October 8, 2025

Total raised: $228M across 2 sourced rounds

Acquired by SSwedish Orphan Biovitrum on December 13, 2025 · Yahoo Finance.

Website: arthrosi.com.

LinkedIn: linkedin.com.

Category: Health and bio.

Sectors: Biotechnology, Life Science, Product Research.

Stage: Series B+.

Based in: San Diego, United States.

Founded: 2018.

Total raised: $228M in 2 sourced rounds.

Last round: Oct 8, 2025 · 400 days ago.

Headcount: 11–50 employees.

On Recent Funding since: Nov 8, 2026.

Signals

Website registeredNov 6, 2016 (10 years old)

TIMELINE · MONEY RAISED

Raised $228M in 2 sourced rounds

Money raised, round by round (amounts linked to their source). Pins are dated signals; hover the icons for dates.

December 13, 2025
Acquired by SSwedish Orphan Biovitrum
Source: Yahoo Finance
October 8, 2025
Series B+ · $153M
PPrime Eight Capital (lead), CCR Biotech, HHighlight Capital, HHM Venture Partners, MMaxpro Ventures, RReliantTech
Source: fundraisingfox.com
July 12, 2023
Series B+ · $75M
GGuangrun Health Industry (lead), RReichstein Biotech
Source: finsmes.com
November 6, 2016
Website created

Sources and API

Every amount links to the page it came from. * Estimated from an accelerator's published standard deal, not a company-specific disclosure. How Recent Funding sources and verifies funding data. The same data as JSON: /api/v1/companies/arthrosi-therapeutics (get a free API key).